EMA Assessing Moderna’s Spikevax Against COVID-19 In 6-11 Year-Olds

Phase II Study Showed A ‘Robust’ Response

 
• By Ian Schofield
  
moderna vaccine in Japan
The Moderna COVID-19 vaccine has been filed for use in younger children • Source: Alamy

More from Europe

More from Geography